市場調查報告書
商品編碼
1287578
黃斑部病變治療市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球黃斑部病變治療市場規模達到89億美元。展望未來,IMARC集團預計,到2028年,市場規模將達到129億美元,在2023-2028年期間呈現6.2%的成長率(CAGR)。
黃斑部病變是一種影響眼睛的神經退行性眼部疾病,會促使視野中心的視力模糊或喪失。特點是視野中的盲點,視覺失真和在弱光條件下無法看清。一些常用的黃斑部病變治療技術包括抗血管生成藥物、光動力雷射療法、隱形眼鏡和過渡性鏡片。雷射療法涉及將專門的隱形眼鏡置入眼睛的受影響部位,透過雷射將其與血管一起封住。抗血管生成藥物用於防止血管的堵塞和滲漏。黃斑部病變治療的及時治療可以幫助提高視力,並將發展成慢性失明的風險降到最低。
與年齡有關的黃斑部病變和群眾中的肥胖症發病率的增加是推動市場成長的關鍵因素之一。飲食模式的改變和擴大採用久坐的生活方式,促使了黃斑部病變的發展。此外,擴大使用智慧手機、筆記型電腦和電視,促使長時間和過度的螢幕時間,也影響了這種疾病的發生。此外,視網膜基因療法的發展,包括將腺相關病毒(AAV)注射到體內以防止異常血管的發展,為市場成長提供了推動力。與此相呼應,醫療基礎設施的顯著改善也對市場成長產生了積極的影響。其他因素,包括為開發創新和有效藥物而進行的廣泛研究和開發(R&D)活動,以及政府為促進公共衛生而實施的各種計劃,預計將推動市場的成長。
The global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.
Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.
The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, stage of disease, route of administration and end user.
Dry Age-related Macular Degeneration
Wet Age-related Macular Degeneration
Early Stage
Intermediate Stage
Late Stage
Intravenous Route
Intravitreal Route
Hospitals
Ambulatory Surgical Center
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.
Key Questions Answered in This Report
1. What was the size of the global macular degeneration treatment market in 2022?
2. What is the expected growth rate of the global macular degeneration treatment market during 2023-2028?
3. What are the key factors driving the global macular degeneration treatment market?
4. What has been the impact of COVID-19 on the global macular degeneration treatment market?
5. What is the breakup of the global macular degeneration treatment market based on the type?
6. What is the breakup of the global macular degeneration treatment market based on the stage of disease?
7. What is the breakup of the global macular degeneration treatment market based on the route of administration?
8. What is the breakup of the global macular degeneration treatment market based on the end user?
9. What are the key regions in the global macular degeneration treatment market?
10. Who are the key players/companies in the global macular degeneration treatment market?